Polaryx Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

PLYX

organization

SIC: 2834

Also known as: Polaryx Therapeutics, Inc.

SEC Insider

$368K

2 transactions

Summary

Polaryx Therapeutics, Inc. (PLYX) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $368KSales: —3 insiders

Date	Insider	Type	Value
2026-05-27	Joint reporting: Yang Alex Keun Mo; Mstone Partners Healthcare Ltd	Buy	$360K
2026-02-18	Landis G. Michael(Chief Financial Officer)	Buy	$8K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Polaryx Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope